Price target
1,717.700.000.00%
The 10 analysts offering 1 year price forecasts for GLENMARK have a max estimate of — and a min estimate of —.
Analyst rating
Based on 10 analysts giving stock ratings to GLENMARK in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
GLENMARK EPS for the last quarter is 12.06 INR despite the estimation of 11.70 INR. In the next quarter EPS is expected to reach 14.70 INR. Track more of GLENMARK PHARMACEUTICALS financials and stay on top of what is up with the company.
In the next quarter GLENMARK PHARMACEUTICALS revenue is expected to reach 34.83 B INR. Check out GLENMARK PHARMACEUTICALS revenue and earnings and make informed decisions.
According to analysts, GLENMARK price target is 1,717.70 INR with a max estimate of 1,900.00 INR and a min estimate of 1,345.00 INR. Check if this forecast comes true in a year, meanwhile watch GLENMARK PHARMACEUTICALS stock price chart and keep track of the current situation with GLENMARK news and stock market news.
We've gathered opinions of 10 analysts rating GLENMARK stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.